The stock market performance of BriaCell Therapeutics Corp has been fairly unsteady. Over the last year, the company’s stock hit its highest at $55.95 on 02/26/24, while the lowest price during the same time frame was $3.33, recorded on 02/10/25.
52-week price history of BCTX Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. BriaCell Therapeutics Corp’s current trading price is -90.90% away from its 52-week high, while its distance from the 52-week low is 52.85%. The stock’s price range for this period has remained between $3.33 and $55.95. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.79 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.38 million over the last three months.
Financial Performance and Market Capitalization
BriaCell Therapeutics Corp (BCTX) has experienced a quarterly decline of -43.48% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 18.88M and boasts a workforce of 18 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 10.02, with a change in price of -5.14. Similarly, BriaCell Therapeutics Corp recorded 308,447 in trading volume during the last 100 days, posting a change of -50.26%.
BCTX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BCTX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
BCTX Stock Stochastic Average
As of today, the raw stochastic average of BriaCell Therapeutics Corp over the last 50 days is at 11.20%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 38.77%. Further, the company’s Stochastic %K and %D values for the last 20 days were 27.90% and 20.34%, respectively.
BCTX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a loss of -39.94%.However, over the last six months, we can see a stronger performance of -39.70%. Over the last 30 days, the price of BCTX has leaped by -11.86%. And in the last five days, it has surged by 40.61%.
